| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 10.71 | 152,300 | 1.63 mm | 152,300 |
| 2 Jan 24 | SPRY ARS Pharmaceuticals | Stock option Common Stock | Grant | Acquire A | No | No | 5.58 | 300,000 | 1.67 mm | 300,000 |
| 29 Sep 23 | SPRY ARS Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 3.783 | 46,258 | 174.99 k | 89,227 |
| 28 Sep 23 | SPRY ARS Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 3.624 | 40,000 | 144.96 k | 42,969 |
